Elos Medtech signs first US distributor agreement
We are pleased to announce a new distributor agreement with Vulcan Custom Dental in the US to provide American customers with selected Elos Accurate® products. Elos Accurate enables an open digital workflow for dentists and dental technicians, which is recognized by a growing number of customers worldwide.
Vulcan Custom Dental, located in Birmingham, Alabama, US, is an advanced prosthesis milling center with a primary focus on dental implant restorations. The company is all about bringing the power of precision manufacturing and advanced dental restorations to dentists and dental technicians. Both company’s dedication to advancing digital dentistry is the basis for our collaboration and future expansion.
The new distributor agreement will allow customers faster deliveries and personal support. The next step is to receive FDA 510(k) clearance to market and launch the complete Elos Accurate portfolio on the US dental implant market.
We are very excited about the new agreement with Vulcan Custom Dental, which affirms our commitment to expanding our dental business to important markets. The new agreement will contribute to reach our sustainable growth targets in North America, says Jan Wahlström, CEO and president.
With this agreement, we are taking the next strategic step into the US market", says Søren Olesen, Managing Director of Elos Medtech Pinol and Global Dental Business Director. "This confirms our dental focus and will serve as a platform for further expansion of our dental product offering in the US".
Elos Medtech is one of the leading development and production partners for medical technology products and components in the world, with focus on dental and orthopedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and the US. Customers are medical technology companies operating internationally.
Elos Medtech employs more than 550 people worldwide and generates revenue that exceeds MSEK 600. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.
Gothenburg, June 19, 2019
Elos Medtech AB (publ)
For further information, contact:
Jan Wahlström, President and CEO, +46 70-212 18 89, email@example.com
Sören Olesen, Managing Director Elos Medtech Pinol and Global Business Director Dental,
+45 40 41 28 82, firstname.lastname@example.org
This is the type of information that Elos Medtech AB (publ) is obliged to publish in accordance with the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was issued for publication by the contact persons stated above on June 19, 2019, at 12.00 (CET).
For additional information about the Elos Medtech Group, visit www.elosmedtech.com